lunes, 2 de octubre de 2023

UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver new anti-cancer therapies Lythgoe et al.

https://www.thelancet.com/journals/lanonc/home?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-8Xdk8h7-PNuDuZVNdgKn7v25D7LgComxZr0M33RqtmMi2fJtkAt_ErBCeJGQ6IdQrUiCkjsrjUV1JDWq_uqt8yeGurDA&utm_content=272344974&utm_source=hs_automation Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer Dean A Fennell https://www.thelancet.com/journals/lanonc/issue/current National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00297-8/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-82V8fdsqrZWWQ7ijqnhiNAFkiXe0voL515TGrtWf73T3bngruy4-9cvWU2Sn_bHiX1ZXMEfwzzxGlx0-PYiyWpCyTwJw&utm_content=272344974&utm_source=hs_automation Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00223-1/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-8QWg5mgDQoqvKc3JLgBlp7wWSHaq_tlHcbcHukJI2RyvM_KiqCTjwZf9Kr0Ggyt2_ieNXUM83eRfZfWEQSJgMdGCiYYg&utm_content=272344974&utm_source=hs_automation Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00005-0/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz--nah1RPKDMLe0p2Lo-Q1C_7foFWP9vZTyWQ3MGwQCG6vkAhPLMqqbtDJ46QSP93sL7DrpOyXIcdX_F7-A25NRg52Lk8A&utm_content=272344974&utm_source=hs_automation Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00067-0/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-_0_ryFvizI_hrMrz0aSTHqRwr6_XtdA0VDNxIij9ZEU8WXhftIuU7bY6ab3iHECAIMWWP_JvB7CpNQdX8XFU7-2ozRSw&utm_content=272344974&utm_source=hs_automation Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00752-5/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz--wJ-9GUaqmyEp5T6TQwVXpN3nEInKcgGcvPv2O3TPAR1-Kj7vAUCQASXIWsrkQ1I6roCAyVVHa438mRY-AXxElJLbn6g&utm_content=272344974&utm_source=hs_automation Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00157-2/fulltext?dgcid=hubspot_email_jcr23_lanonc&utm_campaign=jcr23&utm_medium=email&_hsmi=272344974&_hsenc=p2ANqtz-9Ego-FRZIPFyF7AQ7k-g6NjlNISAI1xCIP0K7VfkRGtd8zUYaVCNLOnHFuWfFRtpfO0WOXJuQTmSwMkRkTe7nBJi26zg&utm_content=272344974&utm_source=hs_automation

No hay comentarios:

Publicar un comentario